FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Comments on Drug Interaction Study Guidance

Two stakeholders give FDA technical comments on a guidance based on an International Council for Harmonization guideline on drug interaction studies.

latest-news-card-1
Medical Devices

FDA Radiology CADe Device Guidance

FDA publishes a guidance on 510(k) submissions for computer-assisted detection devices applied to radiology images and device data.

latest-news-card-1
Medical Devices

Clinical Assessments for Computer Detection Devices Guide

FDA issues a revised final guidance entitled Clinical Performance Assessment: Considerations for Computer-Assisted Detection Devices Applied to Radiol...

latest-news-card-1
Human Drugs

Delta Pharma FDA-483 Released

FDA releases the form FDA-483 with five observations from an inspection at the Ripley, MS-based Delta Pharma outsourcing facility.

latest-news-card-1
Human Drugs

OTC Monograph Submission Format Guidance

FDA publishes a draft guidance on the required electronic format for submission of over-the-counter monographs.

latest-news-card-1
Medical Devices

FDA Changing Covid Test Review Policy

FDA updates its Covid-19 test policy to send more tests through the traditional review pathways and away from emergency use authorizations.

latest-news-card-1
Federal Register

ORA, Field Office Organization Structure Modified

Federal Register notice: FDA modifies the organizational structure of the Office of Regulatory Affairs and field offices.

latest-news-card-1
Medical Devices

Clinical Decision Software Guidance

FDA publishes a guidance explaining the scope of its oversight of clinical decision support software in light of changes mandated by the 21st Century ...

latest-news-card-1
Human Drugs

CGMP Deviations at Zhejiang Tianyu Pharmaceutical

FDA warns Chinas Zhejiang Tianyu Pharmaceutical Co. about CGMP deviations in the production of active pharmaceutical ingredients.

latest-news-card-1
Federal Register

Tissues Office Renamed Office of Therapeutic Products

Federal Register notice: CBERs Office of Tissues and Advanced Therapies has modified its organizational structures to redesignate it a super office t...